Efinaconazole Patent Expiration
Efinaconazole is Used for treating onychomycosis and tinea unguium. It was first introduced by Bausch Health Americas Inc
Efinaconazole Patents
Given below is the list of patents protecting Efinaconazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Jublia | US10478601 | Applicator | Apr 25, 2035 | Bausch |
| Jublia | US10342875 | Stabilized efinaconazole compositions | Oct 02, 2034 | Bausch |
| Jublia | US10828293 | Anti-infective methods, compositions, and devices | Oct 02, 2034 | Bausch |
| Jublia | US10864274 | Stabilized efinaconazole formulations | Oct 02, 2034 | Bausch |
| Jublia | US11654139 | Anti-infective methods, compositions, and devices | Oct 02, 2034 | Bausch |
| Jublia | US9662394 | Stabilized efinaconazole compositions | Oct 02, 2034 | Bausch |
| Jublia | US8486978 | Compositions and methods for treating diseases of the nail | Oct 24, 2030 | Bausch |
| Jublia | US9302009 | Compositions and methods for treating diseases of the nail | Oct 24, 2030 | Bausch |
| Jublia | US10105444 | Compositions and methods for treating diseases of the nail | Jul 08, 2030 | Bausch |
| Jublia | US8039494 | Compositions and methods for treating diseases of the nail | Jul 08, 2030 | Bausch |
| Jublia | US9861698 | Compositions and methods for treating diseases of the nail | Jul 08, 2030 | Bausch |
| Jublia | US10512640 | Compositions and methods for treating diseases of the nail | Jan 03, 2028 | Bausch |
| Jublia | US10828369 | Compositions and methods for treating diseases of the nail | Jan 03, 2028 | Bausch |
| Jublia | US11213519 | Compositions and methods for treating diseases of the nail | Jan 03, 2028 | Bausch |
| Jublia | US11872218 | Compositions and methods for treating diseases of the nail | Jan 03, 2028 | Bausch |
| Jublia | US9566272 | Compositions and methods for treating diseases of the nail | Jan 03, 2028 | Bausch |
| Jublia | US9877955 | Compositions and methods for treating diseases of the nail | Jan 03, 2028 | Bausch |
| Jublia | US7214506 | Method for treating onychomycosis | Feb 22, 2026 | Bausch |
Efinaconazole's Family Patents
Explore Our Curated Drug Screens
Efinaconazole Generics
Several generic applications have been filed for Efinaconazole. The first generic version for Efinaconazole was by Teva Pharmaceuticals Usa Inc and was approved on Dec 16, 2020. And the latest generic version is by Zydus Lifesciences Global Fze and was approved on Jul 15, 2022.
Given below is the list of companies who have filed for Efinaconazole generic.
1. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Efinaconazole. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | solution | Discontinued | TOPICAL | N/A | Mar 29, 2021 |
2. LUPIN LTD
Lupin Ltd has filed for 1 generic for Efinaconazole. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | solution | Discontinued | TOPICAL | N/A | Mar 2, 2022 |
3. PADAGIS US
Padagis Us Llc has filed for 1 generic for Efinaconazole. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | solution | Discontinued | TOPICAL | N/A | Dec 16, 2020 |
4. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Efinaconazole. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | solution | Prescription | TOPICAL | AB | Dec 16, 2020 |
5. UMEDICA
Umedica Laboratories Private Ltd has filed for 1 generic for Efinaconazole. Given below are the details of the strengths of this generic introduced by Umedica.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | solution | Prescription | TOPICAL | AB | Jun 21, 2021 |
6. ZYDUS LIFESCIENCES
Zydus Lifesciences Global Fze has filed for 1 generic for Efinaconazole. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | solution | Discontinued | TOPICAL | N/A | Jul 15, 2022 |